| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.44 | 0.0002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |